sensitivity | specificity | PPV | NPV | accuracy | ||
---|---|---|---|---|---|---|
CT | isodense focus in NECT | 0.93 | 0.74 | 0.36 | 0.99 | 0.76 |
homogeneous enhancement in HAP | 0.84 | 0.77 | 0.36 | 0.97 | 0.78 | |
isodense to liver enhancement in PVP | 0.80 | 0.80 | 0.38 | 0.96 | 0.80 | |
isodense to liver enhancement in EP | 1.00 | 0.43 | 0.22 | 1.00 | 0.51 | |
central scar | 0.53 | 0.99 | 0.89 | 0.93 | 0.93 | |
homogeneous enhancement in HAP and central scar | 0.47 | 0.99 | 0.88 | 0.93 | 0.93 | |
homogeneous enhancement in HAP and isodense to liver enhancement in PVP | 0.71 | 0.95 | 0.67 | 0.96 | 0.92 | |
homogeneous enhancement in HAP and isodense to liver enhancement in PVP no cirrhosis | 0.71 | 0.97 | 0.76 | 0.96 | 0.94 | |
homogeneous enhancement in HAP and isodense to liver enhancement in PVP no neoplastic disease in anamnesis | 0.55 | 0.83 | 0.29 | 0.94 | 0.80 | |
MRI | isointense focus in T1 W | 0.44 | 0.84 | 0.27 | 0.92 | 0.79 |
isointense focus in T2 W | 0.84 | 0.85 | 0.44 | 0.98 | 0.85 | |
central scar | 0.73 | 0.99 | 0.87 | 0.96 | 0.96 | |
homogeneous enhancement in HAP | 0.89 | 0.75 | 0.32 | 0.98 | 0.77 | |
isointense to liver enhancement in PVP | 0.82 | 0.79 | 0.34 | 0.97 | 0.79 | |
non-hypointense focus in HBP | 1.00 | 0.94 | 0.68 | 1.00 | 0.94 | |
homogeneous enhancement in HAP non-hypointense focus in HBP | 0.89 | 0.97 | 0.82 | 0.98 | 0.96 | |
homogeneous enhancement in HAP non-hypointense focus in HBP central scar | 0.64 | 1.00 | 1.00 | 0.95 | 0.96 | |
non-hypointense focus in HBP no neoplastic disease in anamnesis | 0.55 | 0.93 | 0.56 | 0.92 | 0.87 | |
non-hypointense focus in HBP no cirrhosis | 1.00 | 0.99 | 0.94 | 1.00 | 0.99 | |
homogeneous enhancement in HAP no cirrhosis | 0.89 | 0.83 | 0.39 | 0.99 | 0.84 | |
homogeneous enhancement in HAP non-hypointense focus in HBP no cirrhosis | 0.89 | 1.00 | 1.00 | 0.99 | 0.99 |